ArticleJournal of chemical information and modeling2025
AGDIFF: Attention-Enhanced Diffusion for Molecular Geometry Prediction.
Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Accurate prediction of molecular geometries is crucial for drug discovery and materials science. Existing fast conformer prediction algorithms often rely on approximate empirical energy functions, resulting in low accuracy. More accurate methods like ab initio molecular dynamics and Markov chain Monte Carlo can be computationally expensive due to the need for evaluating quantum mechanical energy functions. To address this, we introduce AGDIFF, a novel machine learning framework that utilizes diffusion models for efficient and accurate molecular structure prediction. AGDIFF extends previous models (such as GeoDiff) by enhancing the global, local, and edge encoders with attention mechanisms, an improved SchNet architecture, batch normalization, and feature expansion techniques. AGDIFF outperforms GeoDiff on both the GEOM-QM9 and GEOM-Drugs data sets. For GEOM-QM9, with a threshold (δ) of 0.5 Å, AGDIFF achieves a mean COV-R of 93.08% and a mean MAT-R of 0.1965 Å. On the more complex GEOM-Drugs data set, using δ = 1.25 Å, AGDIFF attains a median COV-R of 100.00% and a mean MAT-R of 0.8237 Å. These findings demonstrate AGDIFF's potential to advance molecular modeling techniques, enabling more efficient and accurate prediction of molecular geometries, thus contributing to computational chemistry, drug discovery, and materials design. https://github.com/ADicksonLab/AGDIFF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.